Skip to main content

Patient Derived Xenograft Models Market | Key Applications Driving Market Growth

“PDX models market is projected to grow at a CAGR of 16.7%”
The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.

Pre-Clinical Drug Development Key Application Driving Growth in Market
Based on application, the PDX models market has been broadly segmented into preclinical drug development & basic cancer research and biomarker analysis. In 2017, the preclinical drug development and basic cancer research segment is expected to account for the largest share of the global patient derived xenograft models market. Growth in this segment is mainly driven by the increasing number of research activities in the field of oncology drug research.

Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251

“Asia Pacific to witness the highest growth during the forecast period”
Asia Pacific is expected to grow at the highest CAGR in the global PDX models market during the forecast period of 2017–2022. Strong research expenditure and the well-structured CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D expenditure in India, and rising translational and biomedical research in Singapore are expected to drive the market growth during the forecast period.

patient-derived-xenograft-model-market1

The report analyzes the PDX models market and aims at estimating the market size and the future growth potential of this market based on various segments such as type, tumor type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Request Sample Report Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=121598251

Key Market Players and Growth Strategies Adopted by Them:
The various players in the PDX models market include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US).

Comments

Popular posts from this blog

Temperature Monitoring Systems Market | 3M (US) and Omega Engineering (US) are Leading Players

Analysis of the developments in the temperature monitoring systems market from 2016 to 2018 shows that new product launches, geographic expansions, mergers & acquisitions, and contracts were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions. Some of the prominent players in the temperature monitoring systems market are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (Subsidiary Of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), and Omega Engineering (US). The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs...

Dental Bone Graft Substitutes Market | Key Market Players

The global dental bone graft substitutes market is expected to reach USD 664.3 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as growing aging population, growing medical and dental tourism in developing countries, and increasing disposable income in developing countries across the globe are fueling the growth of this market. The major players operating in global dental bone graft substitutes market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea). The global dental bone graft substitutes market is fragmented and competitive, with a significant number of global and regional market players. This report studies the growth strategies adopted by key market players between 2013 and 2015. Leading players in the dental bone graft subst...

Cranial Fixation & Stabilization Systems Market 2019 | Top 5 Major Factors Driving Market Growth

Market Growth Factors: The increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries are the key drivers for the global cranial fixation and stabilization systems market . What Expert Analysed About The Market Growth: The global cranial fixation and stabilization systems market is expected to reach USD 1.74 billion by 2022 from USD 1.14 billion in 2017, at a CAGR of 8.7% . Market Segmentation: The cranial fixation and stabilization systems market is segmented on the basis of product, material type, end user, and region. Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197152289 “Cranial fixation systems are expected to grow at the highest CAGR during the forecast period.” Based on product, the market is segmented into cranial fixation systems and cranial stabilization systems. The cranial fixation systems segment is expected to grow at the highest CAGR during the forecast period. The large share of th...